By: Byrne, Newtown, Lawrence, Kang, Asael, Yong, Robert T., Jian, Roichman, Rabinowitz, Song, Ulrike, Bokai, Huang, Mark, Cheng, John, Zhao, Proudfoot, Cao, Shue, Kayothera, Demin, Xiaobing, Fang, Wei, Yibin
Differentiating DCs express ALDH1A2, which produces retinoic acid and suppresses DC activity. Blocking this pathway with a new inhibitor, KyA33, enhances immune responses and boosts the effectiveness of DC cancer vaccines in mouse models.












